Thomas Leggett – Biography
Last update: April 19, 2026Executive profile
Thomas was Chief Financial Officer at Affinia Therapeutics, and Director at Clover Biopharmaceuticals. Thomas Leggett joined Clover Biopharmaceuticals in 2024.
Thomas Leggett is currentlyChief Financial Officer at Stoke Therapeutics - View - Stoke Therapeutics org chart
Independent Non-Executive Director at Clover Biopharmaceuticals - View - Clover Biopharmaceuticals org chart
Create your alert
to follow the career of Thomas Leggett.
Education
Thomas Leggett has a Master of Business Administration in Finance from University of Pennsylvania - The Wharton School.
They have also studied at University of Pennsylvania - The Wharton School :
Find more alumni from University of Pennsylvania - The Wharton School
More about Thomas Leggett
Selected links
Do you need to know more about Thomas Leggett? More results.
Participate
Social media
- Thomas Leggett on Google News, X (Twitter), LinkedIn, YouTube
- View the pictures of Thomas Leggett
The colleagues of Thomas Leggett
Company Colleagues
- At Stoke Therapeutics, Thomas Leggett has 40 colleagues including Ian Smith (CEO), Jennifer Burstein (Director)…
- At Clover Biopharmaceuticals, Thomas Leggett has 20 colleagues including Joshua Liang (CEO), Xiaobin Wu (Director)…
Industry Colleagues
- In the Pharmaceuticals industry, Thomas Leggett has 22,991 colleagues in 1,914 companies located in 68 countries. 10,852 executive movements have been recorded in the last 12 months. Learn more about Pharmaceuticals.
Report an error
Update the org chart details of Thomas Leggett.
Get in Touch
Here are a few tips for establishing great contacts.
and ask for Thomas Leggett.
